<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190929044918N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-11-11</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>The effect of well-being on diabetes</public_title>
      <acronym>بهزیستی درمانی</acronym>
      <scientific_title>Effect of Well being Therapy on Depression, Anxiety, Self-management and Blood Glucose Control in Women with Type 2 Diabetes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-10-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/42590</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Blocking is used to make balance amongst the samples of each group under examination. This feature might be useful when meso-level analysis is needed during sampling process, so that each group is callocatedthe same amount of samples. In this design randomizing shall take place based on permuted blocking. Thus, paitients will be grouped in 15 blocks, each comprisingtwopeople from the experimental group and two people from the control group.Finally, group 1 will be treated using Well-BeingTherapy(WBT) and the control group shall receive notreatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Diabetes.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:The well-being therapy program for diabetic patients is composed of 12 sessions of 90 minutes held once a week for three months.Early sessions (1-2): Preparing the group, building relationships, and introducing the logic of treatment. Clinical interview, getting identification data, information about feelings, current distress, previous distress, defining the curriculum process, defining the structure and conditions of well-being therapy, including the number of sessions, duration of sessions, interval between sessionsMiddle session (2-6): Identifying existing barriers and removing irrelevant beliefs with the aim of self-observation of care seekers to achieve psychological well-being the role of lack of positive emotions, giving the first home workout, explaining the concept of optimal experiences, describing thoughts and behaviors that are detrimental to well-being, explaining the concept of self-therapy, explaining problem solving, self-acceptance and its role in mental relaxationLast sessions (6-12): Introducing six dimensions of model of psychological well-being and changing six damaged dimensions of psychological well-being. environmental mastery as a component of mental health, initiating cognitive reconstruction of thoughts or behaviors that disrupt well-being, personal growth and exploring social cognitive development, the role of dysfunctional cognitions, providing autonomy components and positive relationships with others, summary, emphasizing the importance of continuing self-therapy after the sessions. Intervention 2: This group receives routine caring actions like glycemic control, medical advice, and prescription of medication from the physician of Diabetes Center. However, it does not receive well-being therapy intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I have not yet reviewed which journals to publish</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahnaz Pzhuhshgar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 2, Behvarz 9, Dr. Hesabi 4, Jam Junc., Daneshgah St.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>91899-14878</zip>
        <telephone>+98 51 3866 2507</telephone>
        <email>m.p13978694@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahnaz Pazhushgar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 2, Behvarz 9, Dr. Hesabi 4, Jam Junc., Daneshgah St.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9189913878</zip>
        <telephone>+98 51 3866 2507</telephone>
        <email>m.p13978694@gmial.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Gender: female
Minimum 35 years, maximum 65 years, 3.
Depression score of higher than 19 in the 21-item Beck Depression Inventory (BDI-21)
.Anxiety score of higher than 16 in the 21-item Beck Anxiety Inventory (BAI-21)
Minimum level of Education: high school diploma</inclusion_criteria>
      <agemin>35 years</agemin>
      <agemax>65 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Evidence of severe mental disorder (including personality disorder),
Other simultaneous psychological and medicinal treatments,
Psychiatric medications.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:The well-being therapy program for diabetic patients is composed of 12 sessions of 90 minutes held once a week for three months.Early sessions (1-2): Preparing the group, building relationships, and introducing the logic of treatment. Clinical interview, getting identification data, information about feelings, current distress, previous distress, defining the curriculum process, defining the structure and conditions of well-being therapy, including the number of sessions, duration of sessions, interval between sessionsMiddle session (2-6): Identifying existing barriers and removing irrelevant beliefs with the aim of self-observation of care seekers to achieve psychological well-being the role of lack of positive emotions, giving the first home workout, explaining the concept of optimal experiences, describing thoughts and behaviors that are detrimental to well-being, explaining the concept of self-therapy, explaining problem solving, self-acceptance and its role in mental relaxationLast sessions (6-12): Introducing six dimensions of model of psychological well-being and changing six damaged dimensions of psychological well-being. environmental mastery as a component of mental health, initiating cognitive reconstruction of thoughts or behaviors that disrupt well-being, personal growth and exploring social cognitive development, the role of dysfunctional cognitions, providing autonomy components and positive relationships with others, summary, emphasizing the importance of continuing self-therapy after the sessions</i_keyword>
      <i_keyword>This group receives routine caring actions like glycemic control, medical advice, and prescription of medication from the physician of Diabetes Center. However, it does not receive well-being therapy intervention</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression. Timepoint: At the beginning of the study, both experimental and control groups will be measured before and after the intervention. Method of measurement: Beck Depression Inventory.</prim_outcome>
      <prim_outcome>Anxiety. Timepoint: Both case and control groups are measured at the beginning of the study, before the intervention and after the re-intervention. Method of measurement: Beck Anxiety Inventory.</prim_outcome>
      <prim_outcome>Self-Management. Timepoint: Both case and control groups are measured at the beginning of the study, before the intervention and after the re-intervention. Method of measurement: The Tobert &amp; Thompson Self-Management Questionnaire.</prim_outcome>
      <prim_outcome>Glycemic Control. Timepoint: Both case and control groups are measured at the beginning of the study, before the intervention and after the re-intervention. Method of measurement: Blood sugar test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-07-09</approval_date>
        <contact_name>National Committee on Ethics in Biomedical Research</contact_name>
        <contact_address>Boulevard Emamieh  70 Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
